![Ann Cunningham](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ann Cunningham
Direktor/Vorstandsmitglied bei
VISTAGEN THERAPEUTICS, INC.
Vermögen: - $ am 31.07.2026
Profil
Ann Cunningham is the founder of I3 Strategy Partners LLC.
Ms. Cunningham is currently an Independent Director at Vistagen Therapeutics, Inc. since 2022.
Ms. Cunningham is also an Independent Non-Executive Director at Alterity Therapeutics Ltd. starting in 2026.
Formerly, Ms. Cunningham was Senior Director-Global Brand at Eli Lilly & Co. from 1999 to 2013.
Ms. Cunningham was Senior Marketing Director at Otsuka America Pharmaceutical, Inc. from 2013 to 2015.
Ms. Cunningham was Vice President-Neurodegenerative Disease at Teva Pharmaceutical Industries Ltd. from 2015 to 2018.
Ms. Cunningham completed undergraduate studies at Yale University and earned an MBA from Stephen M.
Ross School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 22.07.2026 | 0 ( -.--% ) | - $ | 31.07.2026 |
Aktive Positionen von Ann Cunningham
| Unternehmen | Position | Beginn |
|---|---|---|
| VISTAGEN THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 10.01.2019 |
| ALTERITY THERAPEUTICS LIMITED | Direktor/Vorstandsmitglied | 17.04.2026 |
Ehemalige bekannte Positionen von Ann Cunningham
| Unternehmen | Position | Ende |
|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | 01.01.2018 |
Otsuka America Pharmaceutical, Inc.
 Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical products | Corporate Officer/Principal | 01.01.2015 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01.01.2013 |
I3 Strategy Partners LLC | Gründer | - |
Ausbildung von Ann Cunningham
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
83
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Teva Pharmaceutical Industries Ltd.
 Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
Alterity Therapeutics Ltd.
 Alterity Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs | Health Technology |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Otsuka America Pharmaceutical, Inc.
Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical products | Health Technology |
Stephen M. Ross School of Business
 Stephen M. Ross School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
VistaGen Therapeutics, Inc.
 VistaGen Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops central nervous system therapies | Health Technology |
I3 Strategy Partners LLC |
